OBIO Competitors & Alternatives
Compare Orchestra BioMed Holdings Inc. with similar stocks in the same industry
Biotechnology
OBIO
Main Stock$6.12
Tradestie Score
42
Market Cap
$137.59M
Revenue Growth
-0.9%
Analyst Upside
+101.5%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$14.63
|
$386.68M | - | 40 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.00
|
$382.04M | - | 45 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.43
|
$371.64M | - | 53 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$20.59
|
$354.45M | - | 41 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$44.63
|
$353.70M | - | 46 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 35 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.27
|
$341.56M | - | 36 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.94
|
$332.96M | - | 42 | Compare |
|
REPL
Replimune Group, Inc.
|
$12.92
|
$328.62M | - | 44 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.82
|
$308.74M | - | 49 | Compare |
More OBIO Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 3841)
237 stocks in this industry